Stopping versus continuing long-term mepolizumab treatment in severe eosinophilic asthma (COMET study).
Eur Respir J. 2022 Jan 6;59(1):2100396. doi: 10.1183/13993003.00396-2021. Print 2022 Jan.
Eur Respir J. 2022.
PMID: 34172470
Free PMC article.
Clinical Trial.